BREZTRI
Active substance: BUDESONIDE, GLYCOPYRROLATE, FORMOTEROL
AEROSOL, METERED · BUDESONIDE 160 ug/1, GLYCOPYRROLATE 18 ug/1, FORMOTEROL 4.8 ug/1
United StatesActive
Marketing holder: AstraZeneca Pharmaceuticals LP
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
Composition
- BUDESONIDE · 160 ug/1
- GLYCOPYRROLATE · 18 ug/1
- FORMOTEROL · 4.8 ug/1
Products containing budesonide in other countries
Showing products with this active substance, combinations included; the full composition is shown for each product.
| Country | Products |
|---|---|
| RU 59 |
|
| EU 11 |
|
Registration
- Registration number
- 0310-6616
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- RESPIRATORY (INHALATION)
Sources
- product · openFDA NDC · 0310-6616 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0310-6616 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0310-6616 · Verified 2026-10-09 · open in source
- ingredients.1 · openFDA NDC · 0310-6616 · Verified 2026-10-09 · open in source
- ingredients.2 · openFDA NDC · 0310-6616 · Verified 2026-10-09 · open in source